Pharmesis International Statistics
Total Valuation
Pharmesis International has a market cap or net worth of SGD 20.45 million. The enterprise value is 23.33 million.
Market Cap | 20.45M |
Enterprise Value | 23.33M |
Important Dates
The last earnings date was Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Pharmesis International has 31.70 million shares outstanding. The number of shares has increased by 15.38% in one year.
Current Share Class | n/a |
Shares Outstanding | 31.70M |
Shares Change (YoY) | +15.38% |
Shares Change (QoQ) | +1.41% |
Owned by Insiders (%) | 48.09% |
Owned by Institutions (%) | n/a |
Float | 6.40M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.30 |
PB Ratio | 2.18 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -16.91 |
EV / Sales | 2.99 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -16.81 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.31.
Current Ratio | 1.08 |
Quick Ratio | 0.47 |
Debt / Equity | 0.31 |
Debt / EBITDA | n/a |
Debt / FCF | -2.19 |
Interest Coverage | -13.26 |
Financial Efficiency
Return on equity (ROE) is -14.74% and return on invested capital (ROIC) is -8.61%.
Return on Equity (ROE) | -14.74% |
Return on Assets (ROA) | -7.58% |
Return on Capital (ROIC) | -8.61% |
Revenue Per Employee | 7,117 |
Profits Per Employee | -1,259 |
Employee Count | 1,096 |
Asset Turnover | 0.51 |
Inventory Turnover | 1.98 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +610.23% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +610.23% |
50-Day Moving Average | 0.42 |
200-Day Moving Average | 0.18 |
Relative Strength Index (RSI) | 64.44 |
Average Volume (20 Days) | 15,105 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharmesis International had revenue of SGD 7.80 million and -1.38 million in losses. Loss per share was -0.05.
Revenue | 7.80M |
Gross Profit | 2.33M |
Operating Income | -1.85M |
Pretax Income | -1.32M |
Net Income | -1.38M |
EBITDA | -1.63M |
EBIT | -1.85M |
Loss Per Share | -0.05 |
Balance Sheet
The company has 642,277 in cash and 3.05 million in debt, giving a net cash position of -2.40 million or -0.08 per share.
Cash & Cash Equivalents | 642,277 |
Total Debt | 3.05M |
Net Cash | -2.40M |
Net Cash Per Share | -0.08 |
Equity (Book Value) | 9.85M |
Book Value Per Share | 0.30 |
Working Capital | 362,832 |
Cash Flow
In the last 12 months, operating cash flow was -1.36 million and capital expenditures -31,340, giving a free cash flow of -1.39 million.
Operating Cash Flow | -1.36M |
Capital Expenditures | -31,340 |
Free Cash Flow | -1.39M |
FCF Per Share | -0.04 |
Margins
Gross margin is 29.82%, with operating and profit margins of -23.69% and -17.69%.
Gross Margin | 29.82% |
Operating Margin | -23.69% |
Pretax Margin | -16.86% |
Profit Margin | -17.69% |
EBITDA Margin | -20.85% |
EBIT Margin | -23.69% |
FCF Margin | -17.80% |
Dividends & Yields
Pharmesis International does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.38% |
Shareholder Yield | -15.38% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on August 27, 2015. It was a reverse split with a ratio of 0.1.
Last Split Date | Aug 27, 2015 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Pharmesis International has an Altman Z-Score of -0.01. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.01 |
Piotroski F-Score | n/a |